| Annual · values | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Cash Flow | -6.50 M USD | -8.51 M USD | -1.18 M USD |
| Depreciation & Amortization | 287961 USD | 267382 USD | 196937 USD |
| Stock-Based Compensation | 1.99 M USD | 1.13 M USD | 281538 USD |
| Capital Expenditures | 169917 USD | 396451 USD | 288712 USD |
| Cash Flow from Investing | -150218 USD | -359216 USD | -311167 USD |
| Cash Flow from Financing | -27709 USD | 18.52 M USD | 1.00 M USD |
| Dividends Paid | — | — | — |
| Stock Buybacks | — | — | — |
| Free Cash Flow | -6.67 M USD | -8.90 M USD | -1.47 M USD |
Exozymes Inc. operates in the biotechnology sector with a focus on developing enzyme-based products for industrial applications. The primary function of Exozymes Inc. is to leverage advanced enzymatic solutions to enhance processes across various industries, including pharmaceuticals, agriculture, and biofuels. Through its innovative approach, the company aims to improve efficiency, reduce environmental impact, and provide sustainable alternatives to traditional chemical processes. Exozymes Inc. plays a key role in the market by offering customizable enzyme solutions that cater to specific industrial needs, thereby driving technological advancements and promoting cleaner manufacturing practices. Its presence underscores the importance of biotechnology in revolutionizing conventional methods and addressing global environmental challenges.